文献速递其他结缔组织病

肿瘤相关皮肌炎中肌炎自身抗原基因的频繁遗传改变

Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis.
PubMed 文献 · Ann Rheum Dis · 2025-11-25

结果显示,多数CAD患者肿瘤(75%)中检测到自身抗体相关基因的体细胞突变和杂合性缺失(LOH),肿瘤特异性错义突变产生高免疫原性新抗原,LOH导致肿瘤中富集等位基因表达而在非肿瘤病变中未观察到,肿瘤内存在克隆扩增的淋巴细胞群。

要点

  • 多数CAD患者肿瘤(75%)中检测到自身抗体相关基因的体细胞突变和LOH。
  • 肿瘤特异性错义突变产生高免疫原性新抗原,LOH导致肿瘤中富集等位基因表达。
  • 肿瘤内存在克隆扩增淋巴细胞群,非肿瘤病变中未观察到。

核心结论

  • 在自身抗体相关基因中检测到高度频繁的遗传改变,支持其在CAD致病机制中的作用。
  • 肿瘤与非肿瘤组织之间不同的TCR库和免疫特征可能 underlie 不同的肿瘤和皮肌炎结局。

研究设计与样本

  • 对可获得的白细胞(生殖系)、肌肉、皮肤和肿瘤样本进行基因组和转录组分析。
  • 进行T细胞受体(TCR)库分析和多重免疫表型分析,以表征肿瘤和非肿瘤组织中的免疫反应。

主要发现

  • 在多数CAD患者肿瘤(75%)中检测到自身抗体相关基因(TRIM33、TRIM66、MORC3、CHD4、IFIH1)的体细胞突变和杂合性缺失(LOH)。
  • 肿瘤特异性错义突变产生高度免疫原性新抗原。
  • LOH导致肿瘤中富集等位基因表达,而在非肿瘤病变(皮肤和肌肉)中未观察到。
  • 免疫表型分析显示肿瘤内存在克隆扩增的淋巴细胞群,但非肿瘤病变中未观察到,提示存在独特的细胞免疫反应。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: One-third of patients diagnosed with dermatomyositis harbour an occult cancer, a rare condition named cancer-associated dermatomyositis (CAD). Emerging evidence suggests that genetic alterations in autoantibody-related genes give rise to neoantigens and specific autoantibodies that initiate an autoimmune response characteristic of CAD. This study evaluated the prevalence of such genetic alterations and elucidated molecular mechanisms that may underlie their role in triggering autoimmunity. METHODS: Fifteen patients with CAD were included in the study. We conducted genomic and transcriptomic analyses of available leukocyte (germline), muscle, skin, and tumour samples. T-cell receptor (TCR) repertoire profiling and multiplex immunophenotyping were performed to characterise immune responses in tumoural and nontumoural tissues. RESULTS: Somatic mutations and loss of heterozygosity (LOH) in autoantibody-related genes as tripartite motif containing 33, tripartite motif containing 66, MORC family CW-type zinc finger 3 (MORC3), Chromodomain Helicase DNA Binding Protein 4, and IFIH1, interferon-induced helicase C domain-containing protein 1-corresponding to known myositis-specific autoantibodies Anti-transcriptional intermediary factor 1 gamma, anti-nuclear matrix protein 2, (anti-transcriptional intermediary factor 1 gamma (anti-TIF1γ), anti-nuclear matrix protein 2 (anti-NXP2), anti-Mi2, antimelanoma differentiation-associated gene 5 protein), were detected in the majority of tumours from patients with CAD (75%). Tumour-specific missense mutations gave rise to highly immunogenic neoantigens, while LOH resulted in enriched allelic expression not observed in nontumoural lesions (skin and muscle). Immunophenotyping revealed a clonally expanded lymphocyte population within tumours, but not in nontumoural lesions, suggesting a distinct cellular immune response. CONCLUSIONS: We detected highly frequent genetic alterations in autoantibody-related genes, supporting their role in the CAD pathogenic mechanisms. Moreover, our findings suggest that distinct TCR repertoire and immune signatures between tumoural and nontumoural tissues may underlie divergent cancer and dermatomyositis outcomes.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Moreno-Cárdenas AB, Ros J, Gil-Vila A, et al. Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis. Ann Rheum Dis. 2025. PMID: 41290487. doi:10.1016/j.ard.2025.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。